Home › Back Pain › NCT06282770
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
Utilizing Photobiomodulation Via Laser Diode Belts To Treat Chronic Lower Back Pain in Patients Who Have Undergone Spinal Fusion and Decompression Surgery
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria: * Subject will have undergone minimally invasive spinal fusion surgery or spinal decompression surgery in their lower back L1-S1. * Have low back pain of \>3 months and a pain threshold of \> 4 (as described by the the subject), age \> 18 years, and English speaking to eliminate possible miscommunication and consequent human error regarding belt use. * Subject must have had surgery at minimum to 1 year prior to start of study and no more than 5 years prior to start to study Exclusion Criteria: * Patients with tumors * Current infection * Drug misuse history * Skin conditions preclude the use of laser belt * Severe spondylolisthesis, spondylolysis, spinal stenosis, ankylosing spondylitis * Previous low back surgery exceeding 5 years to initial start date.
About the study
After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around the operation site and this inflammation can be painful and debilitating to patients.
Many possible treatment plans have been incorporated to assist the patient with recovery - notably medications, physical therapy, and braces. However, few studies have looked at laser diodes that utilize high-power laser lights that are aimed at decreasing pain and inflammation. Investigators aim to look compare patients using a back brace with laser diodes within versus those who wear a normal brace used as a placebo. Investigators will also assess the patient's surgical wound to monitor the progression of wound healing while using the brace.
What is being tested
- Laser Diode Brace (device)
- Sham Laser Diode Brace (device)
Sponsor: University of California, Los Angeles · Participants: 80 · Started: Jul 1, 2023
Contact the study team
- Daniel Lu, Md, PhD · Phone: 310-267-2975
- Sandra Holley, PhD · Phone: 3108252763
Official record on ClinicalTrials.gov — NCT06282770
Locations in the U.S.
| California | Semel Institute of Neuroscience at UCLA, Los Angeles UCLA Clinical and Translational Research Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.